JNJ
Johnson & Johnson · NYSE
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website jnj.com
- Employees(FY) 152700
- ISIN US4781601046
Performance
-2.02%
1W
+0.72%
1M
-8.47%
3M
-2.05%
6M
-4.94%
YTD
-2.45%
1Y
Profile
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Investment Analysis Report: Johnson & Johnson (JNJ)
Overview:
Johnson & Johnson (JNJ) is a leading company in the Health Technology sector, specifically in the Pharmaceuticals: Major industry. With a market capitalization of $389.83 billion, JNJ is a significant player in the healthcare industry. In this report, we will conduct a detaile...
Technical Analysis of JNJ 2024-05-31
Overview:
In analyzing the technical indicators for JNJ over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Indicators:
- Moving Averages (MA): The 5-day MA has been consistently below the closing prices, i...
Recent News & Updates
- 2024-05-25 19:05
10 Best Dividend Aristocrat Stocks To Buy Now(Insidermonkey)
- 2024-05-25 07:30
3 Dow Stocks to Buy on the Dip: May 2024(InvestorPlace)
- 2024-05-25 05:45
- 2024-05-25 01:00
- 2024-05-24 17:45
- 2024-05-24 13:00
- 2024-05-24 12:07
Analyst Report: Johnson & Johnson(Morningstar Research)
- 2024-05-24 03:41
- 2024-05-24 03:23
- 2024-05-23 13:40
ASCO24: An early look at cancer drug study results(BioPharma Dive)
- 2024-05-23 05:22
- 2024-05-23 05:17
Top 20 Largest Publicly Traded Healthcare Companies(Insidermonkey)
- 2024-05-22 23:11
The 500 Top Stocks to Buy in May, According to AI(Investorplace)
- 2024-05-22 21:48
7 Safe-Haven Stocks to Weather Any Storm(Investorplace)
- 2024-05-22 17:22
- 2024-05-22 15:11
- 2024-05-22 13:53
- 2024-05-22 12:24
- 2024-05-22 10:26
- 2024-05-22 09:48
7 Safe-Haven Stocks to Weather Any Storm(InvestorPlace)
- 2024-05-22 06:31
J&J’s Tremfya superior to Stelara in Phase II/III Chron’s disease trial(Clinical Trials Arena)
- 2024-05-22 01:41
- 2024-05-21 13:41
- 2024-05-21 10:57
- 2024-05-21 09:10
- 2024-05-21 07:11
J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial(Clinical Trials Arena)
- 2024-05-21 01:22
- 2024-05-20 22:52
15 Best Quality Dividend Stocks to Buy According to Reddit(Insidermonkey)
- 2024-05-20 18:12
J&J posts latest Varipulse data while awaiting FDA review(Yahoo Finance)
- 2024-05-20 09:21
Weekly Stock List(Argus Research)